Pfizer Turns Vaccines Focus To Pregnant Women And Unborn Children
This article was originally published in The Pink Sheet Daily
Executive Summary
The company envisions maternal immunization as a new prong in its strategy to protect a full spectrum of people from disease through vaccinations, ranging from unborn children to senior citizens.
You may also be interested in...
Pfizer’s Abrysvo Is First Maternal Vaccine For RSV To Protect Infants
The vaccine, already approved for adults, was approved for pregnant women to protect infants from birth up to six months from complications caused by respiratory syncytial virus.
GSK Halts Enrollment In Maternal RSV Vaccine Trials As Setback Intensifies
The company has not revealed any details of the potential safety issue that led to the decision.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.